Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Operations Update

27 Sep 2013 07:00

RNS Number : 0573P
Phorm Corporation Limited
27 September 2013
Β 

27 September 2013

Β 

Phorm Corporation Limited ("Phorm" or the "Company")

Β 

Operations Update

Β 

Revenue and Key Performance Indicators Show Strong Growth

Β 

Β 

Phorm (AIM: PHRM), a leading internet personalization technology company, announces today that it is seeing strong sustained growth in revenue and other key performance indicators.

Β 

Β· 3.6 million monthly opted-in users

Β· 1.2 million active on daily basis, 100% increase from June

Β· Advertising network and publisher partners provide over 1.2 billion requests per month

Β· Over 66 million advertising impressions served in August

Β· Advertising products demonstrating excellent performance

Β· Increasing evidence of market-leading conversion rates

Β 

Phorm previously announced on 28 June that it had reached commercial scale in Turkey such that it was delivering advertising campaigns and that revenue generation had commenced. Despite market activity being at seasonal lows, considerable commercial traction has been achieved over recent months and the Company has seen considerable growth in revenues and other Key Performance Indicators including user numbers, advertising requests and advertising impressions served. In addition, Phorm has received very exciting feedback from its customers, with respect to conversion rates, which demonstrates that its platform has the ability to compete effectively in text advertising.

Β 

Phorm is pleased to announce that the number of daily active users is now 1.2 million, a 100% increase on the number previously announced on 28 June and the rate of growth is increasing. Phorm has now conclusively demonstrated the viability of an opt-in model and is pleased that it continues to lead the market in terms of consumer choice and protection.

Β 

Phorm has continued to sign and build its publisher network. In June, the Company announced that it was receiving an average of 30 million requests per day, this has now grown to over 40 million requests per day. In August the Company received a total of over 1.2 billion advertising requests.

Β 

The number of advertising impressions served by the Company is also continuing to grow. In June the Company served 39 million, this has grown by over 70% to 67 million by the end of August. Phorm is able to serve both display and text advertising, which allows advertisers to target advertising at the key-word level without using a search engine.

Β 

Phorm is also delighted to announce that it has received some excellent feedback from its advertising partners with respect to conversion rates. Conversion is key to ensuring the long-term success of the platform as it is the measure of the proportion of clicks that result in the user action desired by the advertiser; for example to buy a product or fill in an application form. Phorm has demonstrated across a range of sectors and campaigns that its targeted advertising can result in very high conversion rates. In recent campaigns, Phorm has achieved conversion rates of up to 40%.

Β 

The Company is now focused on building its revenue based on these excellent results and will update the market further in due course.

Β 

-ends-

Β 

Contact

Β 

Phorm Corporation Limited

Β 

Andy Croxson (analysts & investors) +44 207 297 2067

Β 

Liberum Capital +44 20 3100 2222 (Nominated Advisor and Joint Broker)

Β 

Chris Bowman

Richard Bootle

Β 

Mirabaud Securities LLP +44 20 7321 2508 (Joint Broker)

Β 

Jason Woollard

Peter Krens

Β 

About Phorm

Β 

Phorm is a global personalization technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

Β 

Phorm's industry leading technology enables its ISP partners to offer a new type of online advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalized content for opted-in users.

Β 

Phorm's advertising platform revolutionizes current standards of online privacy, fully protecting the identity of consumers. Unlike virtually all other targeted advertising propositions, Phorm's solution is completely opt-in. Only those users consenting to the service are profiled and only ever on an anonymous basis.

Β 

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Advertising Networks and Advertisers.

Β 

Phorm, under a predecessor holding company, was admitted to the AIM market of the London Stock Exchange in 2004.

Β 

For more information, please visit: www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTLLFSDAFIRFIV
Date   Source Headline
22nd Feb 20088:25 amRNSStockholder Meeting
14th Feb 20087:01 amRNSISP agreements
1st Feb 20088:55 amRNSExercise of Options
28th Jan 20087:01 amRNSTransfer of Shares
15th Jan 20087:00 amRNSManagement Appointment
11th Jan 20085:01 pmRNSExercise of Options
20th Dec 20075:47 pmRNSDirector/PDMR Shareholding
17th Dec 20071:56 pmRNSExercise of Options
30th Nov 20075:32 pmRNSHolding(s) in Company
7th Nov 20072:06 pmRNSExercise of Options
1st Oct 20077:02 amRNSDirectorate Change
28th Sep 20078:02 amRNSInterim Results
12th Sep 20079:33 amRNSHolding(s) in Company
20th Aug 20077:00 amRNSAIM Rule 26
27th Jul 20073:27 pmRNSDirector/PDMR Shareholding
17th Jul 200710:03 amRNSDirector Change - Replacement
17th Jul 20079:12 amRNSDirectorate Change
13th Jul 20071:26 pmRNSExercise of options
18th Jun 20074:50 pmRNSNotification of Interest
18th Jun 20077:01 amRNSAdditional Listing
15th Jun 20077:58 amRNSStmnt re Share Price Movement
6th Jun 20074:11 pmRNSHolding(s) in Company
21st May 20077:02 amRNSDirectorate Change
16th May 20074:17 pmRNSIssue of Equity
4th May 20077:00 amRNSRe-Organisation
3rd May 20077:01 amRNSRe-Organisation
2nd May 20072:01 pmRNSPress speculation
1st May 20078:20 amRNSSch 1 Update - Phorm, Inc.
27th Apr 20074:27 pmRNSSch 1 Update - Phorm, Inc.
26th Apr 200711:52 amRNSNotification of Holding
26th Apr 200711:24 amRNSResult of AGM
24th Apr 20077:02 amRNSAnnual Results
12th Apr 20073:45 pmRNSExercise of Options
2nd Apr 200711:02 amRNSSchedule 1 - Phorm, Inc
2nd Apr 20077:02 amRNSNotice of AGM
8th Mar 20077:04 amRNSDirectorate Change
27th Feb 20077:04 amRNSIssue of Equity
1st Feb 200712:40 pmRNSHolding(s) in Company
21st Dec 20063:33 pmPRNTotal Voting Rights
6th Dec 200612:21 pmPRNAdditional Listing
3rd Nov 20063:05 pmPRNStatement re Share Price Movement
18th Aug 200610:45 amPRNAdditional Listing
28th Jul 20067:00 amPRNAdditional Listing
25th Jul 200612:00 pmPRN121Media appoints David Dorman as Adviser
25th Jul 200610:45 amPRNShare Incentive Plan
21st Jul 20067:00 amPRNUpdate on Trading in and settlement of common shares
20th Jul 20067:00 amPRNDirector/PDMR Shareholding
19th Jul 20067:00 amPRNUpdate re: ISP Partnership Strategy
23rd Jun 20064:12 pmPRNFormal Notice
16th Jun 20067:00 amPRNAppointment of EVP Operations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.